Savannah Merritt Huckaby, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 301 Professional Park Dr # A, Arkadelphia, AR 71923 Phone: 870-779-1022 Fax: 870-568-0681 |
Byers Eye Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 109 Malone Drive, Arkadelphia, AR 71923 Phone: 870-246-6877 |
Raymond Marc Carozza, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2915 Cypress Rd, Suite B, Arkadelphia, AR 71923 Phone: 870-246-5090 Fax: 870-246-7421 |
Texarkana Eye Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 301 Professional Park Dr Ste A, Arkadelphia, AR 71923 Phone: 870-246-5090 Fax: 870-204-7900 |
Community Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 109 Wp Malone, Arkadelphia, AR 71923 Phone: 870-246-6877 Fax: 870-245-0088 |
Alicia Ellen Byers, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 109 W. P. Malone Road, Arkadelphia, AR 71923 Phone: 870-246-6877 Fax: 870-245-0088 |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 301 Professional Park Dr Ste A, Arkadelphia, AR 71923 Phone: 903-838-0783 Fax: 903-831-6145 |
R Dan Bost, OD PA Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2733 Caddo St, Arkadelphia, AR 71923 Phone: 870-246-2932 Fax: 870-230-1552 |
Arkadelphia Eye Clinic Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 911 Main St, Arkadelphia, AR 71923 Phone: 870-246-5090 Fax: 870-246-7421 |
News Archive
The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The U.S. Food and Drug Administration today announced the award of a $904,000 cooperative agreement to the Pan American Health Organization (PAHO) to research and develop an information hub for medical products and related regulatory processes and systems in the Americas Region.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
The immune system may open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, researchers at Washington University School of Medicine in St. Louis have found.Researchers showed in mice that severe inflammatory responses to an initial UTI cause bladder damage and allow infection to persist longer. After one to two weeks of infection, the bladder wall undergoes additional changes that leave mice more vulnerable to later infection. Suppressing the immune system during initial infection decreases these vulnerabilities, they report Aug. 12 in PLoS Pathogens.
› Verified 5 days ago